Allogene Therapeutics Inc (ALLO) — Financial Flexibility Index
Allogene Therapeutics Inc (ALLO) has a Financial Flexibility Index of -0.24x as of September 2025. Free cash flow of $-29.45 Million (operating CF $-29.69 Million minus capex $243.00K) represents 0% of total liabilities ($124.44 Million). Check ALLO capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Allogene Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Allogene Therapeutics Inc across 8 annual periods. See ALLO current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Allogene Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Allogene Therapeutics Inc. For the full company profile including market capitalisation, see ALLO market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.58x | $-199.61 Million | $-200.30 Million | $126.53 Million | ▲ +12.8% |
| 2023 | -1.81x | $-236.22 Million | $-237.73 Million | $130.60 Million | ▼ -29.9% |
| 2022 | -1.39x | $-215.33 Million | $-220.52 Million | $154.70 Million | ▼ -7.0% |
| 2021 | -1.30x | $-163.37 Million | $-184.81 Million | $125.63 Million | ▼ -292.3% |
| 2020 | -0.33x | $-49.13 Million | $-115.09 Million | $148.21 Million | ▲ +66.0% |
| 2019 | -0.97x | $-86.56 Million | $-137.35 Million | $88.78 Million | ▼ -66.4% |
| 2018 | -0.59x | $-41.42 Million | $-44.65 Million | $70.69 Million | ▲ +100.0% |
| 2017 | -19660.50x | $-39.32 Million | $-44.65 Million | $2.00K | — |